建新股份发布2025年度拟不进行利润分配公告：2025年亏损，暂停分红

公司公告要点

• 不进行2025年度利润分配： 河北建新化工股份有限公司（证券代码：300107，简称“建新股份”）董事会决议，2025年度不派发现金红利、不送红股、不以公积金转增股本。
• 2025年度公司亏损： 经审计，2025年公司实现归属于母公司所有者的净利润为-2,774.2万元，母公司净利润为-2,379.6万元。公司合并报表累计未分配利润为4.88亿元，母公司累计未分配利润为5.07亿元。
• 分红暂停原因： 公司表示，鉴于2025年度亏损，结合经营实际、未来业务发展和资金需求，决定暂停分红以保障公司持续稳定运营，维护全体股东长远利益。
• 未触及风险警示红线： 公司2025年度净利润为负值，但未触发创业板股票上市规则第9.4条关于风险警示的规定。
• 审议流程与合规性： 2026年4月16日，公司第六届董事会第十六次会议以全票通过该议案，后续还需提交2025年度股东大会审议。分红方案符合相关法律法规及公司章程。

详细内容解读

建新股份于2026年4月16日发布公告，披露2025年度利润分配预案。公告指出，公司2025年度将不进行任何形式的利润分配，包括不派发现金红利、不送红股、不以资本公积转增股本。该预案已获董事会全票通过，待股东大会审议。

公告显示，2025年度公司经营出现亏损，归属于母公司所有者的净利润为-27,742,054.62元，母公司实现净利润-23,796,162.79元。虽然公司累计未分配利润依然高达数亿元，但考虑到2025年度亏损以及公司未来发展和流动资金需求，管理层认为暂停分红更有利于公司持续稳定经营和维护股东长远利益。

值得注意的是，公司近三年现金分红累计金额为1,790万余元，2023和2024年分别分红约900万元，但2025年度因亏损未分红。同时，公司近三年研发投入累计1.11亿元，占累计营业收入的6.4%，体现出公司对研发持续投入。2025年营业收入为4.65亿元，较2024年和2023年有所下降。

公告特别强调，公司2025年度净利润为负值，但未触及《深圳证券交易所创业板股票上市规则》第9.4条关于其他风险警示的情形，即不会因本次亏损而被实施ST等风险警示。

对投资者的意义及潜在影响

• 分红暂停可能影响市场信心： 公司2025年不分红，且出现较大幅度的年度亏损，可能影响部分以分红为投资目的的股东信心，对短期股价构成一定压力。
• 经营压力及未来展望需关注： 连续多年未分红可能反映出公司经营压力加大，投资者需关注公司业绩恢复及未来业务发展规划。
• 风险警示未被触发是积极信号： 虽然亏损但未被ST，有助于稳定投资者情绪。
• 高研发投入说明公司有转型升级意愿： 但短期内经营压力较大，投资者需密切关注后续财务和经营表现。

结论

本次公告显示建新股份2025年度出现亏损，暂停分红，虽不会被风险警示，但反映出公司经营面临挑战。投资者需密切关注公司后续业绩恢复、业务调整和现金流状况。分红政策的变化、业绩亏损等均属于影响股价的重要信息。

免责声明：本文内容基于公司公告，旨在为投资者提供信息参考，不构成任何投资建议。投资需谨慎，股市有风险，决策请结合自身实际情况。

Jianxin Chemical Announces No Profit Distribution for 2025 Due to Annual Loss

Key Points of the Announcement

• No Profit Distribution for 2025: Hebei Jianxin Chemical Co., Ltd. (Stock Code: 300107, “Jianxin Chemical”) announced that it will not distribute cash dividends, bonus shares, or convert capital reserve into share capital for the 2025 fiscal year.
• Losses in 2025: According to audited results, the company posted a net loss attributable to the parent company of RMB -27.74 million in 2025, and the parent company itself recorded a net loss of RMB -23.80 million. As of December 31, 2025, retained profits stood at RMB 487.7 million (consolidated) and RMB 507 million (parent company).
• Reasons for Dividend Suspension: Due to the loss in 2025 and considering actual operations, future business development, and capital needs, the company decided to suspend dividends to ensure stable operations and safeguard long-term shareholder interests.
• No Risk Warning Triggered: Despite the loss, the company did not trigger any risk warning clauses as per the GEM Listing Rules (Article 9.4).
• Review and Compliance: The proposal was unanimously approved by the Board on April 16, 2026, and will be submitted to the 2025 shareholders’ meeting. The plan complies with all relevant laws and company regulations.

Detailed Analysis

On April 16, 2026, Jianxin Chemical released its 2025 profit distribution plan, stating that no dividends will be distributed in any form for 2025. This proposal has been unanimously approved by the Board and awaits shareholder approval.

The announcement reveals that the company experienced a significant loss in 2025, with a consolidated net loss of RMB 27.74 million. Despite having over RMB 480 million in retained profits, the management decided to suspend dividends to ensure business stability and meet future capital requirements.

Notably, the company distributed about RMB 9 million in cash dividends in both 2023 and 2024, for a three-year total of RMB 17.9 million. However, due to the 2025 loss, no dividend will be distributed for the year. Over the past three years, the company invested RMB 111 million in R&D, accounting for 6.4% of total revenue, highlighting its commitment to innovation. 2025 revenue was RMB 465 million, a decline from previous years.

The company also clarified that the 2025 loss does not trigger any risk warning under the Shenzhen Stock Exchange GEM Listing Rules, meaning the company will not be subject to special treatment (ST).

Implications for Investors and Potential Impact

• Dividend Suspension May Affect Market Sentiment: The halt in dividends and the annual loss may dampen confidence among yield-focused investors and exert short-term pressure on the stock price.
• Operational Pressure and Outlook: Repeated non-distribution of dividends may indicate rising operational challenges. Investors should monitor the company’s recovery and business strategies.
• No Risk Warning Is a Positive Signal: Despite the loss, not being marked for special treatment helps stabilize investor sentiment.
• Strong R&D Commitment: While the company invests heavily in R&D, near-term operational pressure means close attention to future financial and business performance is warranted.

Conclusion

The announcement signals that Jianxin Chemical faces operational challenges in 2025, as evidenced by the loss and dividend suspension. Although not triggering risk warnings, these changes are material and may affect investor decisions. Investors should closely monitor the company’s subsequent performance, business adjustments, and cash flow status.

Disclaimer: This article is based on the company’s public announcement and is for reference only. It does not constitute investment advice. Please make investment decisions cautiously and consider your own circumstances.

View 建新股份 Historical chart here